Global Rare Disease Diagnostics Markets, 2018-2019 & 2020-2024

Dublin, June 29, 2020 (GLOBE NEWSWIRE) — The “Rare Disease Diagnostics: Technologies and Global Markets” report has been added to ResearchAndMarkets.com’s offering.The scope of the report includes rare disease diagnostic technologies, applications, industries, initiatives, patents and companies. The market for rare disease diagnostic products and services is given for 2018 and 2019, and then forecast through 2024.An overview of the global markets and technologies for rare disease diagnostics and discussion on market opportunities for these technologiesAnalyses of global market trends with data from 2018, 2019 and projections of compound annual growth rates (CAGRs) through 2024Evaluation of current market size, market forecast and description of market driving forcesDetailed market share analysis and quantification of rare disease diagnostics markets by disease class, indication, analysis platform, analysis target, test purpose and regionBriefing about rare disease therapies and how they influence the use of rare disease diagnosticsDetails about Orphan Drug Act and other initiatives for rare diseasesCoverage of the key industries associated with developing and marketing rare disease diagnostics, including the DNA sequencing industry, PCR industry, and laboratory services industryA look at the key industry acquisitions and strategic alliances and discussion on the key partnering trendsProfiles of key companies in the rare disease diagnostics industry, including 10x Genomics Inc., Agilent Technologies Inc., Freenome Inc., GenapSys Inc., Illumina Inc., Myriad Genetics Inc. and PerkinElmer Inc.Market Insights
Rare diseases comprise a growing public health priority, as they affect upward of 300 million people globally and they are difficult to diagnose and treat.Key Topics Covered
Chapter 1 IntroductionStudy Goals and ObjectivesReasons for Doing the StudyScope of ReportMethodologyInformation SourcesGeographical BreakdownChapter 2 Summary and HighlightsRare Disease Diagnostic Technologies and MarketsLarge-Scale Initiatives and ConsortiaRare Disease Diagnostics Market Driving ForcesGlobal Rare Disease Diagnostics MarketsChapter 4 Technology BackgroundRare DiseasesRare Disease Diagnostics Key Genetic Analysis PlatformsSanger SequencingNext-Generation SequencingPolymerase Chain ReactionChapter 5 Rare Disease Diagnostics InitiativesBabySeqBlood Profiling AtlasCancer-IDCancer Moon Shots ProgramChina Precision Medicine InitiativeClinGenClinVarEnding the Diagnostic Odyssey ActEpiFemCareFrance Genomic Medicine PlanFriends of Cancer Research ProjectGlobal Commission to End the Diagnostic Odyssey for Children with a Rare DiseaseIntegration of Imaging and Fluid-Based Tumor Monitoring in Cancer Therapy ProgramLiquid Biopsies and Imaging for Improved Cancer CareMatchmaker ExchangeMillion Veteran ProgramMINDMedSeqPrecancer AtlasPrecision Medicine InitiativePromptQuIPTopMedTreehouse Childhood Cancer InitiativeVery Rare Cancer ConsortiumPopulation Sequencing ProgramsChapter 6 Rare Disease Diagnostic IndustriesSequencing Instrument IndustryLong-Read Sequencing IndustrySequencing Informatic IndustryPolymerase Chain Reaction IndustryGenomic Medicines: Gene Therapy IndustryGenomic Medicines: Genetically Modified Cell Therapy IndustryGenomic Medicines: Gene Editing Therapy IndustryGenomic Medicines: RNA Therapy IndustryRare Disease Diagnostics Artificial Intelligence IndustryChapter 7 Rare Disease Diagnostics Strategic Alliances and AcquisitionsAcquisitionsStrategic AlliancesKey TrendsAlliance SummariesChapter 8 Rare Disease Diagnostics MarketsRare Disease Diagnostics Market Driving ForcesPressing Medical NeedOrphan Drug ActExtensive Late-Stage Clinical Pipeline of Innovative Rare Disease MedicinesRare Disease InitiativesRare Disease Diagnostics MarketsCardiovascularCentral Nervous SystemMetabolic and Endocrine DisordersHematologyImmune System and Inflammation-Related DisordersMusculoskeletalOphthalmologyRare CancersRespiratoryMass SpectrometryMicroarrayNext Generation SequencingPolymerase Chain ReactionSanger SequencingOtherSingle GenesMultiple GenesWhole Genome and Whole Exome MarketOther Genomic VariantsProteinsScreening and Early Detection MarketDiagnosis MarketTherapy Guidance MarketMonitoring MarketNorth AmericaEuropeAsia-PacificRest of the WorldChapter 9 Rare Disease Diagnostics Patents and Intellectual PropertyRare Disease Diagnostics PatentsRelated Gene Editing PatentsGene-Editing Patents: Sangamo Case StudyGene Therapy Delivery PatentsRNA Therapy-Related PatentsCAR T-Cell PatentsChapter 10 Company Profiles
10X Genomics Inc.23Andme Inc.3Billion Inc.Adaptive Biotechnologies Inc.Admera HealthAgilent Technologies Inc.AlcediagAmarantus Bioscience Holdings Inc.Ambry GeneticsArchimedlife LaboratoriesArup LaboratoriesAstridbio Technologies Kft.Asuragen Inc.Athena Diagnostics Inc.Base4 Innovation Ltd.Baylor GeneticsBC PlatformsBerry Genomics Co., Ltd.Bgi ShenzhenBio-Rad Laboratories Inc.Biocept Inc.Cegat GmbhCellmax LifeCelsee DiagnosticsCentogene AgCergentis B.V.Danaher Corp.Dante LabsDevyser AbDiacarta Inc.DiploidDirected Genomics LlcDnanexus Inc.Electronic BiosciencesEpic Sciences Inc.Eurofins ScientificExpedeon AgFabric GenomicsFreenome Inc.Fulgent GeneticsFusion Genomics Corp.Genapsys Inc.Genedx Inc.Genemind Biosciences Co., Ltd.Genetics Research LlcGenexosome Technologies Inc.Genomatix Software GmbhGenome Profiling LlcGenomenonGenomic ExpressionGenomnia SrlGenomoncologyGenooxGenospaceGigagen Inc.Golden HelixGrandomics Biosciences Co., Ltd.GuardiomeHelix Opco LlcHtg Molecular Diagnostics Inc.Illumina Inc.Invitae Inc.Kingmed Diagnostics Center Co., Ltd.Laboratory Corp. Of America Inc.Laboratory For Molecular MedicineLeucine Rich Bio Pvt., Ltd.Loop GenomicsMacrogen Inc.Mayo Medical LaboratoriesMedgenome Labs Pvt., Ltd.Molecular Loop Biosolutions LlcMyriad Genetics Inc.New England BiolabsNewgene Ltd.Nostros GenomicsNovogene Co., Ltd.Oxford Nanopore Technologies Ltd.Pacific Biosciences Of California Inc.Perkinelmer Inc.Personal Genome Diagnostics Inc.Preventiongenetics Inc.Q-State BiosciencesQuantapore Inc.Quantum Biosystems Inc.Quest Diagnostics Inc.Real-Time Genomics Inc.RetrophinRoche Holding AgSeven Bridges Genomics Inc.Sistemas Genomicos SlSoftgenetics LlcSophia GeneticsSpera MedicalStrand Life Sciences Pvt., Ltd.Supratech Micropath Laboratory & Research Institute Pvt., Ltd.Thermo Fisher Scientific Inc.Twist BioscienceFor more information about this report visit https://www.researchandmarkets.com/r/aqkv0iResearch and Markets also offers Custom Research services providing focused, comprehensive and tailored research.CONTACT: ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900